Medicare price negotiations is the threat. Big Pharma is counting on a presidential veto as it’s last line of defense.
Drug companies are huddling for the Democrats’ onslaught
Tagged as: Medicare
More in Uncategorized
-
Most Popular
Past Week
-
Patient modesty in health care matters
Misty Roberts | Conditions -
California’s opioid policy hypocrisy
Kayvan Haddadan, MD | Conditions -
A lesson in empathy from a young patient
Dr. Arshad Ashraf | Physician -
The U.S. gastroenterologist shortage explained
Brian Hudes, MD | Physician -
Understanding the deadly gaps in pediatric dental safety [PODCAST]
The Podcast by KevinMD | Podcast -
My late ADHD diagnosis in med school
Suji Choi | Education
-
Past 6 Months
-
Why you should get your Lp(a) tested
Monzur Morshed, MD and Kaysan Morshed | Conditions -
Rebuilding the backbone of health care [PODCAST]
The Podcast by KevinMD | Podcast -
Direct primary care in low-income markets
Dana Y. Lujan, MBA | Policy -
The flaw in the ACA’s physician ownership ban
Luis Tumialán, MD | Policy -
The paradox of primary care and value-based reform
Troyen A. Brennan, MD, MPH | Policy -
Why CPT coding ambiguity harms doctors
Muhamad Aly Rifai, MD | Physician
-
Recent Posts
-
The U.S. gastroenterologist shortage explained
Brian Hudes, MD | Physician -
Finding your why after career burnout
Jillian Rigert, MD, DMD | Physician -
Cancer care’s financial toxicity [PODCAST]
The Podcast by KevinMD | Podcast -
How pro hockey prepared me for residency challenges
Brett Ponich, MD | Physician -
A pediatrician’s medical service in war and peace
Ronald L. Lindsay, MD | Physician -
How an AI medical scribe saved my practice
Ashten Duncan, MD | Tech
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.







![Understanding the deadly gaps in pediatric dental safety [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)


![Cancer care’s financial toxicity [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)
